Obesity, Cholesterol, and Clear-Cell Renal Cell Carcinoma (RCC)

Advances in Cancer Research

Volumn 107, Issue , 2010, Pages 39-56

  Drabkin, Harry A ^a   Gemmill, Robert M ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; CARRIER PROTEIN; CELL SURFACE RECEPTOR; CHOLESTEROL; ENDOTHELIAL PAS DOMAIN CONTAINING PROTEIN 1; ENDOTHELIAL PAS DOMAIN-CONTAINING PROTEIN 1; ESTRONE; HIF1A PROTEIN, HUMAN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LEPTIN; LIPID; RNF139 PROTEIN, HUMAN; STEROL REGULATORY ELEMENT BINDING PROTEIN; VBP1 PROTEIN, HUMAN;

BIOSYNTHESIS; FAMILIAL CANCER; GENETICS; HUMAN; KIDNEY CARCINOMA; KIDNEY TUMOR; METABOLISM; OBESITY; REVIEW;

ADIPONECTIN; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CARCINOMA, RENAL CELL; CARRIER PROTEINS; CHOLESTEROL; ESTRONE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; KIDNEY NEOPLASMS; LEPTIN; LIPIDS; NEOPLASTIC SYNDROMES, HEREDITARY; OBESITY; RECEPTORS, CELL SURFACE; STEROL REGULATORY ELEMENT BINDING PROTEINS;

EID: 77951642773     PISSN: 0065230X     EISSN: 21625557     Source Type: Book Series    
DOI: 10.1016/S0065-230X(10)07002-8     Document Type: Chapter

References (93)

1. Adams, K.F., Leitzmann, M.F., Albanes, D., Kipnis, V., Moore, S.C., Schatzkin, A., Chow, W.H., Body size and renal cell cancer incidence in a large US cohort study. Am. J. Epidemiol. 168 (2008), 268–277.
2. An, J., Rettig, M.B., Mechanism of von Hippel-Lindau protein-mediated suppression of nuclear factor kappa B activity. Mol. Cell. Biol. 25 (2005), 7546–7556.
3. Attoub, S., Noe, V., Pirola, L., Bruyneel, E., Chastre, E., Mareel, M., Wymann, M.P., Gespach, C., Leptin promotes invasiveness of kidney and colonic epithelial cells via phosphoinositide 3-kinase-, rho-, and rac-dependent signaling pathways. FASEB J. 14 (2000), 2329–2338.
4. Baba, M., Hong, S.B., Sharma, N., Warren, M.B., Nickerson, M.L., Iwamatsu, A., Esposito, D., Gillette, W.K., Hopkins, R.F. 3rd, Hartley, J.L., et al. Folliculin encoded by the BHD gene interacts with a binding protein, FNIP1, and AMPK, and is involved in AMPK and mTOR signaling. Proc. Natl. Acad. Sci. USA 103 (2006), 15552–15557.
5. Baba, M., Furihata, M., Hong, S.B., Tessarollo, L., Haines, D.C., Southon, E., Patel, V., Igarashi, P., Alvord, W.G., Leighty, R., et al. Kidney-targeted Birt-Hogg-Dube gene inactivation in a mouse model: Erk1/2 and Akt-mTOR activation, cell hyperproliferation, and polycystic kidneys. J. Natl. Cancer Inst. 100 (2008), 140–154.
6. Barresi, V., Tuccari, G., Barresi, G., Adiponectin immunohistochemical expression in colorectal cancer and its correlation with histological grade and tumour microvessel density. Pathology 41 (2009), 533–538.
7. Beg, Z.H., Stonik, J.A., Brewer, H.B. Jr., Characterization and regulation of reductase kinase, a protein kinase that modulates the enzymic activity of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. Proc. Natl. Acad. Sci. USA 76 (1979), 4375–4379.
8. Bergmann, S., Junker, K., Henklein, P., Hollenberg, M.D., Settmacher, U., Kaufmann, R., PAR-type thrombin receptors in renal carcinoma cells: PAR1-mediated EGFR activation promotes cell migration. Oncol. Rep. 15 (2006), 889–893.
9. Bouloumie, A., Drexler, H.C., Lafontan, M., Busse, R., Leptin, the product of Ob gene, promotes angiogenesis. Circ. Res. 83 (1998), 1059–1066.
10. Brakenhielm, E., Veitonmaki, N., Cao, R., Kihara, S., Matsuzawa, Y., Zhivotovsky, B., Funahashi, T., Cao, Y., Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis. Proc. Natl. Acad. Sci. USA 101 (2004), 2476–2481.
11. Brauweiler, A., Lorick, K.L., Lee, J.P., Tsai, Y.C., Chan, D., Weissman, A.M., Drabkin, H.A., Gemmill, R.M., RING-dependent tumor suppression and G2/M arrest induced by the TRC8 hereditary kidney cancer gene. Oncogene 26 (2007), 2263–2271.
12. Brock, K.E., Gridley, G., Chiu, B.C., Ershow, A.G., Lynch, C.F., Cantor, K.P., Dietary fat and risk of renal cell carcinoma in the USA: A case-control study. Br. J. Nutr. 101 (2009), 1228–1238.
13. Brugarolas, J.B., Vazquez, F., Reddy, A., Sellers, W.R., Kaelin, W.G. Jr., TSC2 regulates VEGF through mTOR-dependent and -independent pathways. Cancer Cell 4 (2003), 147–158.
14. Chang, A.J., Song, D.H., Wolfe, M.M., Attenuation of peroxisome proliferator-activated receptor gamma (PPARgamma) mediates gastrin-stimulated colorectal cancer cell proliferation. J. Biol. Chem. 281 (2006), 14700–14710.
15. Chang, T.Y., Li, B.L., Chang, C.C., Urano, Y., Acyl-coenzyme A:cholesterol acyltransferases. Am. J. Physiol. 297 (2009), E1–E9.
16. Chiu, B.C., Gapstur, S.M., Chow, W.H., Kirby, K.A., Lynch, C.F., Cantor, K.P., Body mass index, physical activity, and risk of renal cell carcinoma. Int. J. Obes. 30 (2006), 940–947.
17. Chow, W.H., Devesa, S.S., Contemporary epidemiology of renal cell cancer. Cancer J. (Sudbury, MA) 14 (2008), 288–301.
18. Clasper, S., Royston, D., Baban, D., Cao, Y., Ewers, S., Butz, S., Vestweber, D., Jackson, D.G., A novel gene expression profile in lymphatics associated with tumor growth and nodal metastasis. Cancer Res. 68 (2008), 7293–7303.
19. Decastro, G.J., McKiernan, J.M., Epidemiology, clinical staging, and presentation of renal cell carcinoma. Urol. Clin. North Am. 35 (2008), 581–592 vi.
20. Doran, A.C., Meller, N., Cutchins, A., Deliri, H., Slayton, R.P., Oldham, S.N., Kim, J.B., Keller, S.R., McNamara, C.A., The helix-loop-helix factors Id3 and E47 are novel regulators of adiponectin. Circ. Res. 103 (2008), 624–634.
21. Fang, X., Sweeney, G., Mechanisms regulating energy metabolism by adiponectin in obesity and diabetes. Biochem. Soc. Trans. 34 (2006), 798–801.
22. Flegal, K.M., Graubard, B.I., Williamson, D.F., Gail, M.H., Cause-specific excess deaths associated with underweight, overweight, and obesity. JAMA 298 (2007), 2028–2037.
23. Gebhard, R.L., Clayman, R.V., Prigge, W.F., Figenshau, R., Staley, N.A., Reesey, C., Bear, A., Abnormal cholesterol metabolism in renal clear cell carcinoma. J. Lipid Res. 28 (1987), 1177–1184.
24. Gemmill, R.M., West, J.D., Boldog, F., Tanaka, N., Robinson, L.J., Smith, D.I., Li, F., Drabkin, H.A., The hereditary renal cell carcinoma 3;8 translocation fuses FHIT to a patched-related gene, TRC8. Proc. Natl. Acad. Sci. USA 95 (1998), 9572–9577.
25. Gemmill, R.M., Bemis, L.T., Lee, J.P., Sozen, M.A., Baron, A., Zeng, C., Erickson, P.F., Hooper, J.E., Drabkin, H.A., The TRC8 hereditary kidney cancer gene suppresses growth and functions with VHL in a common pathway. Oncogene 21 (2002), 3507–3516.
26. Gemmill, R.M., Lee, J.P., Chamovitz, D.A., Segal, D., Hooper, J.E., Drabkin, H.A., Growth suppression induced by the TRC8 hereditary kidney cancer gene is dependent upon JAB1/CSN5. Oncogene 24 (2005), 3503–3511.
27. Ghosh, P.M., Mott, G.E., Ghosh-Choudhury, N., Radnik, R.A., Stapleton, M.L., Ghidoni, J.J., Kreisberg, J.I., Lovastatin induces apoptosis by inhibiting mitotic and post-mitotic events in cultured mesangial cells. Biochim. Biophys. Acta 1359 (1997), 13–24.
28. Gimelli, S., Beri, S., Drabkin, H.A., Gambini, C., Gregorio, A., Fiorio, P., Zuffardi, O., Gemmill, R.M., Giorda, R., Gimelli, G., The tumor suppressor gene TRC8/RNF139 is disrupted by a constitutional balanced translocation t(8;22)(q24.13;q11.21) in a young girl with dysgerminoma. Mol. Cancer, 8, 2009, 52.
29. Goetze, S., Bungenstock, A., Czupalla, C., Eilers, F., Stawowy, P., Kintscher, U., Spencer-Hansch, C., Graf, K., Nurnberg, B., Law, R.E., et al. Leptin induces endothelial cell migration through Akt, which is inhibited by PPARgamma-ligands. Hypertension 40 (2002), 748–754.
30. Greer, E.L., Oskoui, P.R., Banko, M.R., Maniar, J.M., Gygi, M.P., Gygi, S.P., Brunet, A., The energy sensor AMP-activated protein kinase directly regulates the mammalian FOXO3 transcription factor. J. Biol. Chem. 282 (2007), 30107–30119.
31. Guerre-Millo, M., Adiponectin: An update. Diabetes Metab. 34 (2008), 12–18.
32. Hasumi, Y., Baba, M., Ajima, R., Hasumi, H., Valera, V.A., Klein, M.E., Haines, D.C., Merino, M.J., Hong, S.B., Yamaguchi, T.P., et al. Homozygous loss of BHD causes early embryonic lethality and kidney tumor development with activation of mTORC1 and mTORC2. Proc. Natl. Acad. Sci. USA 106 (2009), 18722–18727.
33. Hongo, S., Watanabe, T., Arita, S., Kanome, T., Kageyama, H., Shioda, S., Miyazaki, A., Leptin modulates ACAT1 expression and cholesterol efflux from human macrophages. Am. J. Physiol. 297 (2009), E474–E482.
34. Horiguchi, A., Sumitomo, M., Asakuma, J., Asano, T., Zheng, R., Asano, T., Nanus, D.M., Hayakawa, M., Increased serum leptin levels and over expression of leptin receptors are associated with the invasion and progression of renal cell carcinoma. J. Urol. 176 (2006), 1631–1635.
35. Horiguchi, A., Sumitomo, M., Asakuma, J., Asano, T., Zheng, R., Asano, T., Nanus, D.M., Hayakawa, M., Leptin promotes invasiveness of murine renal cancer cells via extracellular signal-regulated kinases and rho dependent pathway. J. Urol. 176 (2006), 1636–1641.
36. Horiguchi, A., Ito, K., Sumitomo, M., Kimura, F., Asano, T., Hayakawa, M., Decreased serum adiponectin levels in patients with metastatic renal cell carcinoma. Jpn J. Clin. Oncol. 38 (2008), 106–111.
37. Horton, J.D., Goldstein, J.L., Brown, M.S., SREBPs: Activators of the complete program of cholesterol and fatty acid synthesis in the liver. J. Clin. Invest. 109 (2002), 1125–1131.
38. Hua, X., Nohturfft, A., Goldstein, J.L., Brown, M.S., Sterol resistance in CHO cells traced to point mutation in SREBP cleavage-activating protein. Cell 87 (1996), 415–426.
39. Hughes, M.D., Kapllani, E., Alexander, A.E., Burk, R.D., Schoenfeld, A.R., HIF-2alpha downregulation in the absence of functional VHL is not sufficient for renal cell differentiation. Cancer Cell Int., 7, 2007, 13.
40. Isaacs, J.S., Jung, Y.J., Mole, D.R., Lee, S., Torres-Cabala, C., Chung, Y.L., Merino, M., Trepel, J., Zbar, B., Toro, J., et al. HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: Novel role of fumarate in regulation of HIF stability. Cancer Cell 8 (2005), 143–153.
41. Izem, L., Morton, R.E., Possible role for intracellular cholesteryl ester transfer protein in adipocyte lipid metabolism and storage. J. Biol. Chem. 282 (2007), 21856–21865.
42. Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., Smigal, C., Thun, M.J., Cancer statistics, 2006. CA Cancer J. Clin. 56 (2006), 106–130.
43. Kaelin, W.G. Jr., The von Hippel-Lindau tumor suppressor gene and kidney cancer. Clin. Cancer Res. 10 (2004), 6290S–6295S.
44. Kaelin, W.G., The von Hippel-Lindau tumor suppressor protein: Roles in cancer and oxygen sensing. Cold Spring Harb. Symp. Quant. Biol. 70 (2005), 159–166.
45. Kanayama, T., Arito, M., So, K., Hachimura, S., Inoue, J., Sato, R., Interaction between sterol regulatory element-binding proteins and liver receptor homolog-1 reciprocally suppresses their transcriptional activities. J. Biol. Chem. 282 (2007), 10290–10298.
46. Kim, C.M., Vocke, C., Torres-Cabala, C., Yang, Y., Schmidt, L., Walther, M., Linehan, W.M., Expression of hypoxia inducible factor-1alpha and 2alpha in genetically distinct early renal cortical tumors. J. Urol. 175 (2006), 1908–1914.
47. Kita, A., Yamasaki, H., Kuwahara, H., Moriuchi, A., Fukushima, K., Kobayashi, M., Fukushima, T., Takahashi, R., Abiru, N., Uotani, S., et al. Identification of the promoter region required for human adiponectin gene transcription: Association with CCAAT/enhancer binding protein-beta and tumor necrosis factor-alpha. Biochem. Biophys. Res. Commun. 331 (2005), 484–490.
48. Klinghoffer, Z., Yang, B., Kapoor, A., Pinthus, J.H., Obesity and renal cell carcinoma: Epidemiology, underlying mechanisms and management considerations. Expert Rev. Anticancer Ther. 9 (2009), 975–987.
49. Lee, J.N., Song, B., DeBose-Boyd, R.A., Ye, J., Sterol-regulated degradation of Insig-1 mediated by the membrane-bound ubiquitin ligase gp78. J. Biol. Chem. 281 (2006), 39308–39315.
50. Lee, J., Brauweiler, A., Rudolph, M., Hooper, J.E., Drabkin, H.A., Gemmill, R.M., TRC8 is sterol regulated and interacts with lipid and protein biosynthetic pathways. Mol. Cancer Res. 8:1 (2010), 93–106.
51. Li, L., Zhang, L., Zhang, X., Yan, Q., Minamishima, Y.A., Olumi, A.F., Mao, M., Bartz, S., Kaelin, W.G. Jr., Hypoxia-inducible factor linked to differential kidney cancer risk seen with type 2A and type 2B VHL mutations. Mol. Cell. Biol. 27 (2007), 5381–5392.
52. Lim, C.T., Kola, B., Korbonits, M., AMPK as a mediator of hormonal signalling. J. Mol. Endocrinol., 22, 2009, 22.
53. Lipworth, L., Tarone, R.E., McLaughlin, J.K., The epidemiology of renal cell carcinoma. J. Urol. 176 (2006), 2353–2358.
54. Lorick, K.L., Jensen, J.P., Fang, S., Ong, A.M., Hatakeyama, S., Weissman, A.M., RING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination. Proc. Natl. Acad. Sci. USA 96 (1999), 11364–11369.
55. Matsumoto, K., Fujiwara, Y., Nagai, R., Yoshida, M., Ueda, S., Expression of two isozymes of acyl-coenzyme A: Cholesterol acyltransferase-1 and -2 in clear cell type renal cell carcinoma. Int. J. Urol. 15 (2008), 166–170.
56. Mukhin, Y.V., Gooz, M., Raymond, J.R., Garnovskaya, M.N., Collagenase-2 and -3 mediate epidermal growth factor receptor transactivation by bradykinin B2 receptor in kidney cells. J. Pharmacol. Exp. Ther. 318 (2006), 1033–1043.
57. Nickerson, M.L., Warren, M.B., Toro, J.R., Matrosova, V., Glenn, G., Turner, M.L., Duray, P., Merino, M., Choyke, P., Pavlovich, C.P., et al. Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dube syndrome. Cancer Cell 2 (2002), 157–164.
58. Nohturfft, A., Hua, X., Brown, M.S., Goldstein, J.L., Recurrent G-to-A substitution in a single codon of SREBP cleavage-activating protein causes sterol resistance in three mutant Chinese hamster ovary cell lines. Proc. Natl. Acad. Sci. USA 93 (1996), 13709–13714.
59. Okuda, H., Saitoh, K., Hirai, S., Iwai, K., Takaki, Y., Baba, M., Minato, N., Ohno, S., Shuin, T., The von Hippel-Lindau tumor suppressor protein mediates ubiquitination of activated atypical protein kinase. C. J. Biol. Chem. 276 (2001), 43611–43617.
60. Ouchi, N., Kobayashi, H., Kihara, S., Kumada, M., Sato, K., Inoue, T., Funahashi, T., Walsh, K., Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells. J. Biol. Chem. 279 (2004), 1304–1309.
61. Paillasse, M.R., de Medina, P., Amouroux, G., Mhamdi, L., Poirot, M., Silvente-Poirot, S., Signaling through cholesterol esterification: A new pathway for the cholecystokinin 2 receptor involved in cell growth and invasion. J. Lipid Res. 50 (2009), 2203–2211.
62. Pascual, D., Borque, A., Epidemiology of kidney cancer. Adv. Urol., 2008 782381.
63. Pinthus, J.H., Kleinmann, N., Tisdale, B., Chatterjee, S., Lu, J.P., Gillis, A., Hamlet, T., Singh, G., Farrokhyar, F., Kapoor, A., Lower plasma adiponectin levels are associated with larger tumor size and metastasis in clear-cell carcinoma of the kidney. Eur. Urol. 54 (2008), 866–873.
64. Pischon, T., Lahmann, P.H., Boeing, H., Tjonneland, A., Halkjaer, J., Overvad, K., Klipstein-Grobusch, K., Linseisen, J., Becker, N., Trichopoulou, A., et al. Body size and risk of renal cell carcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC). Int. J. Cancer 118 (2006), 728–738.
65. Poland, K.S., Azim, M., Folsom, M., Goldfarb, R., Naeem, R., Korch, C., Drabkin, H.A., Gemmill, R.M., Plon, S.E., A constitutional balanced t(3;8)(p14;q24.1) translocation results in disruption of the TRC8 gene and predisposition to clear cell renal cell carcinoma. Genes Chromosomes Cancer 46 (2007), 805–812.
66. Pollard, P.J., Briere, J.J., Alam, N.A., Barwell, J., Barclay, E., Wortham, N.C., Hunt, T., Mitchell, M., Olpin, S., Moat, S.J., et al. Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations. Hum. Mol. Genet. 14 (2005), 2231–2239.
67. Porstmann, T., Santos, C.R., Griffiths, B., Cully, M., Wu, M., Leevers, S., Griffiths, J.R., Chung, Y.L., Schulze, A., SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth. Cell Metab. 8 (2008), 224–236.
68. Rawson, R.B., Zelenski, N.G., Nijhawan, D., Ye, J., Sakai, J., Hasan, M.T., Chang, T.Y., Brown, M.S., Goldstein, J.L., Complementation cloning of S2P, a gene encoding a putative metalloprotease required for intramembrane cleavage of SREBPs. Mol. Cell 1 (1997), 47–57.
69. Reeves, G.K., Pirie, K., Beral, V., Green, J., Spencer, E., Bull, D., Cancer incidence and mortality in relation to body mass index in the Million Women Study: Cohort study. BMJ (Clinical Research ed.), 335, 2007, 1134.
70. Righi, V., Mucci, A., Schenetti, L., Tosi, M.R., Grigioni, W.F., Corti, B., Bertaccini, A., Franceschelli, A., Sanguedolce, F., Schiavina, R., et al. Ex vivo HR-MAS magnetic resonance spectroscopy of normal and malignant human renal tissues. Anticancer Res. 27 (2007), 3195–3204.
71. Roe, J.S., Kim, H., Lee, S.M., Kim, S.T., Cho, E.J., Youn, H.D., p53 stabilization and transactivation by a von Hippel-Lindau protein. Mol. Cell 22 (2006), 395–405.
72. Rowley, C.W., Staloch, L.J., Divine, J.K., McCaul, S.P., Simon, T.C., Mechanisms of mutual functional interactions between HNF-4alpha and HNF-1alpha revealed by mutations that cause maturity onset diabetes of the young. Am. J. Physiol. Gastrointest. Liver Physiol. 290 (2006), G466–G475.
73. Sakai, J., Rawson, R.B., Espenshade, P.J., Cheng, D., Seegmiller, A.C., Goldstein, J.L., Brown, M.S., Molecular identification of the sterol-regulated luminal protease that cleaves SREBPs and controls lipid composition of animal cells. Mol. Cell 2 (1998), 505–514.
74. Samanic, C., Chow, W.H., Gridley, G., Jarvholm, B., Fraumeni, J.F. Jr., Relation of body mass index to cancer risk in 362,552 Swedish men. Cancer Causes Control 17 (2006), 901–909.
75. Sato, R., Yang, J., Wang, X., Evans, M.J., Ho, Y.K., Goldstein, J.L., Brown, M.S., Assignment of the membrane attachment, DNA binding, and transcriptional activation domains of sterol regulatory element-binding protein-1 (SREBP-1). J. Biol. Chem. 269 (1994), 17267–17273.
76. Schiefelbein, D., Goren, I., Fisslthaler, B., Schmidt, H., Geisslinger, G., Pfeilschifter, J., Frank, S., Biphasic regulation of HMG-CoA reductase expression and activity during wound healing and its functional role in the control of keratinocyte angiogenic and proliferative responses. J. Biol. Chem. 283 (2008), 15479–15490.
77. Seo, J.B., Moon, H.M., Noh, M.J., Lee, Y.S., Jeong, H.W., Yoo, E.J., Kim, W.S., Park, J., Youn, B.S., Kim, J.W., et al. Adipocyte determination- and differentiation-dependent factor 1/sterol regulatory element-binding protein 1c regulates mouse adiponectin expression. J. Biol. Chem. 279 (2004), 22108–22117.
78. Setiawan, V.W., Stram, D.O., Nomura, A.M., Kolonel, L.N., Henderson, B.E., Risk factors for renal cell cancer: The multiethnic cohort. Am. J. Epidemiol. 166 (2007), 932–940.
79. Shackelford, D.B., Shaw, R.J., The LKB1–AMPK pathway: Metabolism and growth control in tumour suppression. Nat. Rev. 9 (2009), 563–575.
80. Sharpe, L.J., Brown, A.J., Rapamycin down-regulates LDL-receptor expression independently of SREBP-2. Biochem. Biophys. Res. Commun. 373 (2008), 670–674.
81. Sierra-Honigmann, M.R., Nath, A.K., Murakami, C., Garcia-Cardena, G., Papapetropoulos, A., Sessa, W.C., Madge, L.A., Schechner, J.S., Schwabb, M.B., Polverini, P.J., et al. Biological action of leptin as an angiogenic factor. Science (New York, NY) 281 (1998), 1683–1686.
82. Spyridopoulos, T.N., Petridou, E.T., Dessypris, N., Terzidis, A., Skalkidou, A., Deliveliotis, C., Chrousos, G.P., Inverse association of leptin levels with renal cell carcinoma: Results from a case-control study. Hormones (Athens, Greece) 8 (2009), 39–46.
83. Teresi, R.E., Waite, K.A., PPARgamma, PTEN, and the Fight against Cancer. PPAR Res., 2008, 2008 932632.
84. Tomita, K., Tamiya, G., Ando, S., Kitamura, N., Koizumi, H., Kato, S., Horie, Y., Kaneko, T., Azuma, T., Nagata, H., et al. AICAR, an AMPK activator, has protective effects on alcohol-induced fatty liver in rats. Alcohol. Clin. Exp. Res. 29 (2005), 240S–245S.
85. Tugnoli, V., Trinchero, A., Tosi, M.R., Evaluation of the lipid composition of human healthy and neoplastic renal tissues. Ital. J. Biochem. 53 (2004), 169–182.
86. Yang, T., Espenshade, P.J., Wright, M.E., Yabe, D., Gong, Y., Aebersold, R., Goldstein, J.L., Brown, M.S., Crucial step in cholesterol homeostasis: Sterols promote binding of SCAP to INSIG-1, a membrane protein that facilitates retention of SREBPs in ER. Cell 110 (2002), 489–500.
87. Yang, H., Minamishima, Y.A., Yan, Q., Schlisio, S., Ebert, B.L., Zhang, X., Zhang, L., Kim, W.Y., Olumi, A.F., Kaelin, W.G. Jr., pVHL acts as an adaptor to promote the inhibitory phosphorylation of the NF-kappaB agonist Card9 by CK2. Mol. Cell 28 (2007), 15–27.
88. Yao, M., Zhou, R.H., Petreaca, M., Zheng, L., Shyy, J., Martins-Green, M., Activation of sterol regulatory element-binding proteins (SREBPs) is critical in IL-8-induced angiogenesis. J. Leukoc. Biol. 80 (2006), 608–620.
89. Yokoyama, C., Wang, X., Briggs, M.R., Admon, A., Wu, J., Hua, X., Goldstein, J.L., Brown, M.S., SREBP-1, a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene. Cell 75 (1993), 187–197.
90. Yoon, S., Lee, M.Y., Park, S.W., Moon, J.S., Koh, Y.K., Ahn, Y.H., Park, B.W., Kim, K.S., Up-regulation of acetyl-CoA carboxylase alpha and fatty acid synthase by human epidermal growth factor receptor 2 at the translational level in breast cancer cells. J. Biol. Chem. 282 (2007), 26122–26131.
91. Zager, R.A., Kalhorn, T.F., Changes in free and esterified cholesterol: Hallmarks of acute renal tubular injury and acquired cytoresistance. Am. J. Pathol. 157 (2000), 1007–1016.
92. Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. Role of AMP-activated protein kinase in mechanism of metformin action. J. Clin. Invest. 108 (2001), 1167–1174.
93. −/− tumors. Mol. Cancer Res. 2 (2004), 89–95.